Last reviewed · How we verify
Meclan (MECLOCYCLINE)
Meclan (generic name: MECLOCYCLINE) is a meclocycline Small molecule drug developed by Johnson And Johnson. It is currently FDA-approved for Acne vulgaris, Actinomycotic infection, Acute bacterial sinusitis.
Meclan, also known as SNX-1012 or meclochlorine, is a small molecule used in clinical trials for various conditions, including stomatitis, oral mucositis, and bronchopulmonary dysplasia. It has been studied in a phase 2 clinical trial as a potential treatment for oral mucositis.
At a glance
| Generic name | MECLOCYCLINE |
|---|---|
| Sponsor | Johnson And Johnson |
| Drug class | meclocycline |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- Acne vulgaris
- Actinomycotic infection
- Acute bacterial sinusitis
- Acute gonococcal cervicitis
- Acute gonococcal endometritis
- Acute gonococcal urethritis
- Anthrax
- Bronchitis
- Brucellosis
- Chancroid
- Gingivostomatitis
- Gonorrhea
- Gonorrhea of pharynx
- Gonorrhea of rectum
- Granuloma inguinale
- Haemophilus Influenzae Acute Otitis Media
- Haemophilus Influenzae Pharyngitis
- Inclusion conjunctivitis
- Infection due to Staphylococcus aureus
- Infection of skin AND/OR subcutaneous tissue
Common side effects
Key clinical trials
- Trimebutine on the Development of Adverse Events Related to the Helicobacter Pylori Eradication Medications (PHASE4)
- No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants (PHASE2)
- Efficacy of SNX-1012 in the Treatment of Oral Mucositis (PHASE2)
- The Effect of Cataract Extraction on the Contractility of Ciliary Muscle (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Meclan CI brief — competitive landscape report
- Meclan updates RSS · CI watch RSS
- Johnson And Johnson portfolio CI
Frequently asked questions about Meclan
What is Meclan?
What is Meclan used for?
Who makes Meclan?
What is the generic name of Meclan?
What drug class is Meclan in?
What development phase is Meclan in?
Related
- Drug class: All meclocycline drugs
- Manufacturer: Johnson And Johnson — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Acne vulgaris
- Indication: Drugs for Actinomycotic infection
- Indication: Drugs for Acute bacterial sinusitis
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing